Synthesis, Structure, and Stability of Copper(II) Complexes Containing Imidazoline-Phthalazine Ligands with Potential Anticancer Activity
Abstract
Recently, there has been great interest in metallopharmaceuticals as potential anticancer agents. In this context, presented studies aim to synthesize and evaluate of two copper(II) complexes derived from phthalazine- and imidazoline-based ligands against on three human cancer cell lines: cervix epithelial cell line (HeLa), breast epithelial-like adenocarcinoma (MCF-7), and triple–negative breast epithelial cancer cell line (MDA-MB-231), as well as non-tumorigenic cell line (HDFa). Moreover their antimicrobial, and antioxidant properties were assessed.
Citations
-
0
CrossRef
-
0
Web of Science
-
0
Scopus
Authors (7)
Cite as
Full text
full text is not available in portal
Keywords
Details
- Category:
- Articles
- Type:
- artykuły w czasopismach
- Published in:
-
Pharmaceuticals
no. 18,
ISSN: 1424-8247 - Language:
- English
- Publication year:
- 2025
- Bibliographic description:
- Balewski Ł., Inkielewicz-Stępniak I., Gdaniec M., Turecka K., Hering A., Ordyszewska A., Kornicka A.: Synthesis, Structure, and Stability of Copper(II) Complexes Containing Imidazoline-Phthalazine Ligands with Potential Anticancer Activity// Pharmaceuticals -,iss. 3 (2025), s.375-
- DOI:
- Digital Object Identifier (open in new tab) 10.3390/ph18030375
- Sources of funding:
-
- Free publication
- Verified by:
- Gdańsk University of Technology
seen 0 times
Recommended for you
Quinoline-based thiazolyl-hydrazones target cancer cells through autophagy inhibition
- V. Ćurčić,
- M. Olszewski,
- N. Maciejewska
- + 11 authors
2024